首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes
【2h】

Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes

机译:姜黄素改善自身免疫性糖尿病。 1型糖尿病加速鼠模型的证据

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Type 1 diabetes (T1DM) is a T cell-mediated autoimmune disease that selectively destroys pancreatic β cells. The only possible cure for T1DM is to control autoimmunity against β cell-specific antigens. We explored whether the natural compound curcumin, with anti-oxidant and anti-inflammatory activities, might down-regulate the T cell response that destroys pancreatic β cells to improve disease outcome in autoimmune diabetes. We employed two accelerated autoimmune diabetes models: (i) cyclophosphamide (CYP) administration to non-obese diabetic (NOD) mice and (ii) adoptive transfer of diabetogenic splenocytes into NODscid mice. Curcumin treatment led to significant delay of disease onset, and in some instances prevented autoimmune diabetes by inhibiting pancreatic leucocyte infiltration and preserving insulin-expressing cells. To investigate the mechanisms of protection we studied the effect of curcumin on key immune cell populations involved in the pathogenesis of the disease. Curcumin modulates the T lymphocyte response impairing proliferation and interferon (IFN)-γ production through modulation of T-box expressed in T cells (T-bet), a key transcription factor for proinflammatory T helper type 1 (Th1) lymphocyte differentiation, both at the transcriptional and translational levels. Also, curcumin reduces nuclear factor (NF)-κB activation in T cell receptor (TCR)-stimulated NOD lymphocytes. In addition, curcumin impairs the T cell stimulatory function of dendritic cells with reduced secretion of proinflammatory cytokines and nitric oxide (NO) and low surface expression of co-stimulatory molecules, leading to an overall diminished antigen-presenting cell activity. These in-vitro effects correlated with ex-vivo analysis of cells obtained from curcumin-treated mice during the course of autoimmune diabetes. These findings reveal an effective therapeutic effect of curcumin in autoimmune diabetes by its actions on key immune cells responsible for β cell death.
机译:1型糖尿病(T1DM)是一种T细胞介导的自身免疫性疾病,可选择性破坏胰腺β细胞。 T1DM的唯一可能治愈方法是控制针对β细胞特异性抗原的自身免疫。我们探讨了天然化合物姜黄素是否具有抗氧化和抗炎活性,是否可能下调破坏胰腺β细胞的T细胞反应,从而改善自身免疫性糖尿病的疾病预后。我们采用了两种加速的自身免疫性糖尿病模型:(i)对非肥胖糖尿病(NOD)小鼠施用环磷酰胺(CYP)和(ii)将糖尿病性脾细胞过继转移至NODscid小鼠中。姜黄素治疗导致疾病发作的显着延迟,并且在某些情况下通过抑制胰腺白细胞浸润并保存表达胰岛素的细胞来预防自身免疫性糖尿病。为了研究保护机制,我们研究了姜黄素对参与疾病发病机理的关键免疫细胞群体的影响。姜黄素通过调节T细胞中表达的T-box(T-bet)来调节T淋巴细胞反应,从而削弱增殖和干扰素(IFN)-γ的产生,T-box是促炎性T辅助1型(Th1)淋巴细胞分化的关键转录因子,两者在转录和翻译水平。同样,姜黄素可减少T细胞受体(TCR)刺激的NOD淋巴细胞中的核因子(NF)-κB活化。此外,姜黄素通过减少促炎性细胞因子和一氧化氮(NO)的分泌以及共刺激分子的低表面表达,削弱了树突状细胞的T细胞刺激功能,从而导致抗原呈递细胞的总体活性降低。这些体外作用与自身免疫性糖尿病过程中从姜黄素治疗的小鼠体内获得的细胞的体外分析有关。这些发现揭示姜黄素通过对负责β细胞死亡的关键免疫细胞的作用而有效治疗自身免疫性糖尿病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号